In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) closed the day trading at $35.62 down -8.62% from the previous closing price of $38.98. In other words, the price has decreased by -$8.62 from its previous closing price. On the day, 1.91 million shares were traded. CRNX stock price reached its highest trading level at $39.5254 during the session, while it also had its lowest trading level at $35.51.
Ratios:
For a better understanding of CRNX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.38 and its Current Ratio is at 16.38. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 06, 2024, initiated with a Buy rating and assigned the stock a target price of $68.
On January 16, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $50.
On December 21, 2023, Jefferies started tracking the stock assigning a Hold rating and target price of $35.Jefferies initiated its Hold rating on December 21, 2023, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’25 when Pizzuti Dana sold 15,000 shares for $52.09 per share. The transaction valued at 781,350 led to the insider holds 29,248 shares of the business.
DANA J PIZZUTI bought 15,000 shares of CRNX for $781,323 on Jan 03 ’25. On Dec 02 ’24, another insider, Struthers Richard Scott, who serves as the President & CEO of the company, sold 10,000 shares for $57.57 each. As a result, the insider received 575,700 and left with 100,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRNX now has a Market Capitalization of 3303313152 and an Enterprise Value of 2493185280. Its current Enterprise Value per Revenue stands at 2399.601 whereas that against EBITDA is -8.188.
Stock Price History:
The Beta on a monthly basis for CRNX is 0.62, which has changed by 0.05952704 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, CRNX has reached a high of $62.53, while it has fallen to a 52-week low of $35.24. The 50-Day Moving Average of the stock is -34.71%, while the 200-Day Moving Average is calculated to be -30.20%.
Shares Statistics:
Over the past 3-months, CRNX traded about 730.84K shares per day on average, while over the past 10 days, CRNX traded about 937190 shares per day. A total of 92.74M shares are outstanding, with a floating share count of 86.88M. Insiders hold about 6.31% of the company’s shares, while institutions hold 88.25% stake in the company. Shares short for CRNX as of 1735603200 were 6919827 with a Short Ratio of 9.47, compared to 1732838400 on 6010613. Therefore, it implies a Short% of Shares Outstanding of 6919827 and a Short% of Float of 7.6.
